Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324519 · ClinicalTrials.gov registry record · Phase 4
Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester
A Phase 4 study of Induced Abortion and Pregnancy Trimester, Second, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00324519: Completed Phase 4 study of Induced Abortion and Pregnancy Trimester, Second, sponsored by University of Florida.
NCT00324519 is a Phase 4 study of Induced Abortion and Pregnancy Trimester, Second that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00324519, a Phase 4 study of Induced Abortion and Pregnancy Trimester, Second, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two methods of pregnancy termination on the time to delivery in the second trimester.
Conditions Studied
Interventions
- DEVICE Foley bulb
- DRUG misoprostol
Study Locations (1)
Florida
- Shands Hospital at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
What the finished NCT00324519 record still lists
NCT00324519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Induced Abortion appearing as the primary indexed condition, and to 2 interventions - of which Foley bulb is the first listed.
NCT00324519 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00324519 about?
NCT00324519 is a clinical study titled "Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester". The purpose of this study is to compare two methods of pregnancy termination on the time to delivery in the second trimester.
What is the current status of trial NCT00324519?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2005-02. Estimated completion is 2007-04.
What conditions does trial NCT00324519 study?
This clinical trial studies the following conditions: Induced Abortion, Pregnancy Trimester, Second.
What interventions are being tested in trial NCT00324519?
The interventions under investigation include: Foley bulb (DEVICE), misoprostol (DRUG).
Who is sponsoring clinical trial NCT00324519?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00324519 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Induced Abortion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00324519's enrollment target sits among peer trials
30 1552nd of 2000 higher than 368 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia